Oct 16, 2017 12:30 pm UTC| Business
VANCOUVER, British Columbia, Oct. 16, 2017 -- MGX Minerals Inc. (“MGX” or the “Company”) (CSE:XMG) (FKT:1MG) (OTCQB:MGXMF) and engineering partner PurLucid Treatment Solutions (“PurLucid”) are pleased to announce...
Ruby Tuesday To Be Acquired By NRD Capital For $2.40 Per Share
Oct 16, 2017 12:30 pm UTC| Business
MARYVILLE, Tenn., Oct. 16, 2017 -- Ruby Tuesday, Inc. (NYSE:RT) today announced an agreement to be acquired by a fund managed by NRD Capital (“NRD”), an Atlanta-based private equity firm that specializes in franchised...
Mitel Hosted Cloud Solutions Trusted by More Than One Million Global Subscribers
Oct 16, 2017 12:30 pm UTC| Business
Represents move by businesses of all sizes to cloud communications.Reflects a market-leading position toward robust, yet simple tools for collaboration.Provides customers with an intuitive and proactive path to cloud...
Asterias Biotherapeutics Announces $10.4 Million Registered Direct Offering
Oct 16, 2017 12:30 pm UTC| Business
FREMONT, Calif., Oct. 16, 2017 -- Asterias Biotherapeutics, Inc. (NYSE American:AST), a biotechnology company focused on the field of regenerative medicine, today announced that it entered into a securities purchase...
AzurRx Announces Addition of Dr. Vern Lee Schramm to the Board of Directors
Oct 16, 2017 12:30 pm UTC| Business
NEW YORK, Oct. 16, 2017 -- AzurRx BioPharma, Inc. (NASDAQ:AZRX) (“AzurRx” or the “Company”) a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases today announced...
Oct 16, 2017 12:30 pm UTC| Business
CAMBRIDGE, Mass., Oct. 16, 2017 -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicines to treat rare...
Oct 16, 2017 12:30 pm UTC| Business
80+ Month Overall Survival (HR = 0.63, Pvalue = 0.02) Discussed in the 285 Patient Sub-group Treated with ThermoDox® plus Standardized Radiofrequency Ablation (sRFA) Ongoing Phase III OPTIMA Study to Confirm Hypothesis...